Met-tox

Arsenicum Album, Avena Sativa,lycopodium Clavatum,natrum Muriaticum,nux Vomica,phytolacca Decandrarhamnus Frangula,solidago Virgaurea,trifolium Pratense,heavy Metal Nosodes

White Manufacturing Inc Dba Micro-west
Human Otc Drug
NDC 61657-0526

Met-tox also known as Arsenicum Album, Avena Sativa,lycopodium Clavatum,natrum Muriaticum,nux Vomica,phytolacca Decandrarhamnus Frangula,solidago Virgaurea,trifolium Pratense,heavy Metal Nosodes is a human otc drug labeled by 'White Manufacturing Inc Dba Micro-west'. National Drug Code (NDC) number for Met-tox is 61657-0526. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Met-tox drug includes Activated Charcoal - 12 [hp_X]/30mL Aluminum - 12 [hp_X]/30mL Antimony - 12 [hp_X]/30mL Arsenic - 12 [hp_X]/30mL Arsenic Trioxide - 12 [hp_X]/30mL Avena Sativa Flowering Top - 3 [hp_X]/30mL Barium - 12 [hp_X]/30mL Berberis Vulgaris Root Bark - 3 [hp_X]/30mL Beryllium - 12 [hp_X]/30mL Boron - 12 [hp_X]/30mL and more. The currest status of Met-tox drug is Active.

Drug Information:

Drug NDC:	61657-0526
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Met-tox
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Arsenicum Album, Avena Sativa,lycopodium Clavatum,natrum Muriaticum,nux Vomica,phytolacca Decandrarhamnus Frangula,solidago Virgaurea,trifolium Pratense,heavy Metal Nosodes
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	White Manufacturing Inc Dba Micro-west
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACTIVATED CHARCOAL - 12 [hp_X]/30mL ALUMINUM - 12 [hp_X]/30mL ANTIMONY - 12 [hp_X]/30mL ARSENIC - 12 [hp_X]/30mL ARSENIC TRIOXIDE - 12 [hp_X]/30mL AVENA SATIVA FLOWERING TOP - 3 [hp_X]/30mL BARIUM - 12 [hp_X]/30mL BERBERIS VULGARIS ROOT BARK - 3 [hp_X]/30mL BERYLLIUM - 12 [hp_X]/30mL BORON - 12 [hp_X]/30mL Load more... BROMINE - 12 [hp_X]/30mL CADMIUM - 12 [hp_X]/30mL CALCIUM - 12 [hp_X]/30mL CERIUM - 12 [hp_X]/30mL CESIUM - 12 [hp_X]/30mL CHLORIDE ION - 12 [hp_X]/30mL CHROMIUM - 12 [hp_X]/30mL COBALT - 12 [hp_X]/30mL COPPER - 12 [hp_X]/30mL DYSPROSIUM - 12 [hp_X]/30mL ERBIUM - 12 [hp_X]/30mL EUROPIUM - 12 [hp_X]/30mL FLUORIDE ION - 12 [hp_X]/30mL FRANGULA ALNUS BARK - 3 [hp_X]/30mL GADOLINIUM - 12 [hp_X]/30mL GALLIUM - 12 [hp_X]/30mL GOLD - 12 [hp_X]/30mL HAFNIUM - 12 [hp_X]/30mL HOLMIUM - 12 [hp_X]/30mL HYDROGEN - 12 [hp_X]/30mL INDIUM - 12 [hp_X]/30mL IODINE - 12 [hp_X]/30mL IRIDIUM - 12 [hp_X]/30mL IRON - 12 [hp_X]/30mL LEAD - 12 [hp_X]/30mL LITHIUM - 12 [hp_X]/30mL LUTETIUM - 12 [hp_X]/30mL LYCOPODIUM CLAVATUM SPORE - 12 [hp_X]/30mL MAGNESIUM - 12 [hp_X]/30mL MERCURY - 12 [hp_X]/30mL MOLYBDENUM - 12 [hp_X]/30mL NEODYMIUM - 12 [hp_X]/30mL NIOBIUM - 12 [hp_X]/30mL NITROGEN - 12 [hp_X]/30mL OSMIUM - 12 [hp_X]/30mL PALLADIUM - 12 [hp_X]/30mL PHYTOLACCA AMERICANA ROOT - 3 [hp_X]/30mL PLATINUM - 12 [hp_X]/30mL POTASSIUM - 12 [hp_X]/30mL PRASEODYMIUM - 12 [hp_X]/30mL RHODIUM - 12 [hp_X]/30mL RUBIDIUM - 12 [hp_X]/30mL RUTHENIUM - 12 [hp_X]/30mL SAMARIUM - 12 [hp_X]/30mL SCANDIUM - 12 [hp_X]/30mL SELENIUM - 12 [hp_X]/30mL SILICON - 12 [hp_X]/30mL SILVER - 12 [hp_X]/30mL SODIUM - 12 [hp_X]/30mL SODIUM CHLORIDE - 12 [hp_X]/30mL SOLIDAGO VIRGAUREA FLOWERING TOP - 3 [hp_X]/30mL STRONTIUM - 12 [hp_X]/30mL STRYCHNOS NUX-VOMICA SEED - 12 [hp_X]/30mL SULFUR - 12 [hp_X]/30mL TANTALUM - 12 [hp_X]/30mL TELLURIUM - 12 [hp_X]/30mL TERBIUM - 12 [hp_X]/30mL THORIUM - 12 [hp_X]/30mL TIN - 12 [hp_X]/30mL TITANIUM - 12 [hp_X]/30mL TRIFOLIUM PRATENSE FLOWER - 3 [hp_X]/30mL VANADIUM - 12 [hp_X]/30mL YTTERBIUM - 12 [hp_X]/30mL YTTRIUM - 12 [hp_X]/30mL ZINC - 12 [hp_X]/30mL ZIRCONIUM - 12 [hp_X]/30mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	24 Jan, 2006
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	wHITE mANUFACTURING INC DBA MICRO-WEST
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	M0003153 N0000175901 N0000175597 N0000020074 N0000185508 N0000175629 N0000184306 M0000728 M0005152 N0000175831 N0000008595 N0000008924 N0000175830 N0000185375 N0000185001 M0016962 M0516536
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	2P3VWU3H10 CPD4NFA903 9IT35J3UV3 N712M78A8G S7V92P67HO MA9CQJ3F7F 24GP945V5T 1TH8Q20J0U OW5102UV6N N9E3X5056Q Load more... SBV4XY874G 00BH33GNGH SY7Q814VUP 30K4522N6T 1KSV9V4Y4I Q32ZN48698 0R0008Q3JB 3G0H8C9362 789U1901C5 1D4N45714Q 77B218D3YE 444W947O8O Q80VPU408O S2D77IH61R AU0V1LM3JT CH46OC8YV4 79Y1949PYO X71938L1DO W1XX32SQN1 7YNJ3PO35Z 045A6V3VFX 9679TC07X4 44448S9773 E1UOL152H7 2P299V784P 9FN79X2M3F 5H0DOZ21UJ C88X29Y479 I38ZP9992A FXS1BY2PGL 81AH48963U 2I87U3734A 05175J654G N762921K75 2E7M255OPY 5TWQ1V240M 11E6VI8VEG 49DFR088MY RWP5GA015D NKN7EZA750 DMK383DSAC MLT4718TJW 7UI0TKC3U5 42OD65L39F YUJ4U1EW7R H6241UJ22B Z4152N8IUI 3M4G523W1G 9NEZ333N27 451W47IQ8X 5405K23S50 YZS2RPE8LE 269XH13919 70FD1KFU70 6424HBN274 NQA0O090ZJ 06SSF7P179 60YU5MIG9W 387GMG9FH5 D1JT611TNE 4JS0838828 00J9J9XKDE MNQ4O4WSI1 58784XQC3Y J41CSQ7QDS C6V6S92N3C
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Phosphate Chelating Activity [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Calcium [EPC] Phosphate Binder [EPC] Standardized Chemical Allergen [EPC] Copper-containing Intrauterine Device [EPC] Non-Standardized Plant Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE] Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Inhibit Ovum Fertilization [PE] Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Calcium [CS] Allergens [CS] Copper [CS] Plant Proteins [CS] Seed Storage Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Calcium [CS] Calcium [EPC] Cell-mediated Immunity [PE] Copper [CS] Copper-containing Intrauterine Device [EPC] Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Increased Histamine Release [PE] Increased IgG Production [PE] Increased Large Intestinal Motility [PE] Inhibit Ovum Fertilization [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Mood Stabilizer [EPC] Non-Standardized Plant Allergenic Extract [EPC] Osmotic Activity [MoA] Osmotic Laxative [EPC] Phosphate Binder [EPC] Phosphate Chelating Activity [MoA] Plant Proteins [CS] Potassium Compounds [CS] Potassium Salt [EPC] Seed Storage Proteins [CS] Standardized Chemical Allergen [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
61657-0526-1	30 mL in 1 BOTTLE, DROPPER (61657-0526-1)	24 Jan, 2006	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Met-tox

Arsenicum Album & more..

Liquid
wHITE mANUFACTURING INC DBA MICRO-WEST
NDC: 61657-0526

Purpose:

For the temporary relief of exhaustion, weakness, aching, soreness and restlessness

Product Elements:

Met-tox arsenicum album, avena sativa,lycopodium clavatum,natrum muriaticum,nux vomica,phytolacca decandrarhamnus frangula,solidago virgaurea,trifolium pratense,heavy metal nosodes alcohol arsenic trioxide arsenic cation (3+) avena sativa flowering top avena sativa flowering top berberis vulgaris root bark berberis vulgaris root bark lycopodium clavatum spore lycopodium clavatum spore sodium chloride sodium cation strychnos nux-vomica seed strychnos nux-vomica seed phytolacca americana root phytolacca americana root frangula alnus bark frangula alnus bark solidago virgaurea flowering top solidago virgaurea flowering top trifolium pratense flower trifolium pratense flower iron iron magnesium magnesium sulfur sulfur chromium chromium aluminum aluminum calcium calcium activated charcoal activated charcoal silicon silicon selenium selenium zinc zinc boron boron cobalt cobalt beryllium beryllium tin tin antimony antimony cerium cerium cesium cesium arsenic arsenic zirconium zirconium strontium strontium neodymium neodymium lead lead chloride ion chloride ion lithium lithium cation copper copper bromine bromine sodium sodium cation yttrium yttrium iodine iodine gadolinium gadolinium fluoride ion fluoride ion samarium samarium cadmium cadmium dysprosium dysprosium mercury mercury titanium titanium potassium potassium cation rubidium rubidium erbium erbium vanadium vanadium scandium scandium ruthenium ruthenium lutetium lutetium holmium holmium praseodymium praseodymium terbium terbium barium barium tellurium tellurium niobium niobium palladium palladium hafnium hafnium tantalum tantalum molybdenum molybdenum europium europium gallium gallium gold gold osmium osmium platinum platinum rhodium rhodium indium indium silver silver thorium thorium iridium iridium hydrogen hydrogen nitrogen nitrogen ytterbium ytterbium

Indications and Usage:

Indications: for the temporary relief of exhaustion, weakness, aching, soreness and restlessness

Warnings:

Warning :stop use and call a doctor if symptoms persist or worsen. if pregnant or breast feeding, consult a healthcare professional before use. contains alcohol: in case of accidental overdose, consult a poison control center immediately

Dosage and Administration:

Directions directions: take 6 drops orally, 4 times a day. for ages 2 to adult

Package Label Principal Display Panel:

Package label ndc 61657-0526-1 micro-west homeopathic met tox product #: 0526 1.0 fl oz. (29.6 ml) ethanol 20% 1.0 fl oz. bottle label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.